Literature DB >> 8434946

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody.

M Kimoto1, H Tsuji, T Ogawa, K Sasaoka.   

Abstract

In order to elucidate the biological role of NG,NG-dimethylarginine dimethylaminohydrolase (EC 3.5.3.18), we prepared monoclonal antibodies (mAbs) against the enzyme from rat kidney and examined the distribution of the enzyme in rats. Four mAbs have been obtained by the fusion of the spleen cells from BALB/c mouse immunized with the sodium dodecyl sulfate-denatured or native enzyme and P3X63Ag8U1 myeloma cells. All the mAbs were shown to bind to the denatured enzyme, but none of them could recognize the native enzyme. The occurrence of the enzyme protein in various rat tissues and cell systems such as peritoneal neutrophils and macrophages was examined using an immunoblotting technique with one of the mAbs. The immunoblotting analyses showed that the enzyme protein is widely distributed in rats, particularly, in kidney, pancreas, liver, brain, and aorta at high concentrations. Furthermore, the enzyme protein was clearly shown to exist in peritoneal neutrophils and macrophages. Since NG-monomethylarginine and NG,NG-dimethylarginine have been suggested to be specific blockers of the systems generating nitric oxide (NO), the above findings are of great interest in connection with the regulation of the NO production in such tissues and cell systems as aorta, brain, peritoneal neutrophils, and macrophages.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434946     DOI: 10.1006/abbi.1993.1091

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  23 in total

1.  Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients.

Authors:  Michiel P C Siroen; Reiner Wiest; Milan C Richir; Tom Teerlink; Jan A Rauwerda; Friedrich T Drescher; Niels Zorger; Paul A M van Leeuwen
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

2.  MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters.

Authors:  Laura G Di Pasqua; Clarissa Berardo; Vittoria Rizzo; Plinio Richelmi; Anna Cleta Croce; Mariapia Vairetti; Andrea Ferrigno
Journal:  Mol Cell Biochem       Date:  2016-06-29       Impact factor: 3.396

Review 3.  [Asymmetric dimethylarginine (ADMA): A cardiovascular risk factor].

Authors:  Friedrich Mittermayer; Katarzyna Krzyzanowska; Michael Wolzt
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 4.  Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

Authors:  Chris Baylis
Journal:  Nat Clin Pract Nephrol       Date:  2006-04

5.  Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases.

Authors:  J M Leiper; J Santa Maria; A Chubb; R J MacAllister; I G Charles; G S Whitley; P Vallance
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

6.  Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease.

Authors:  S Xiao; L Wagner; R J Schmidt; C Baylis
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

Review 7.  The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis.

Authors:  James Leiper; Manasi Nandi
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

8.  The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease.

Authors:  Latika Sibal; Sharad C Agarwal; Philip D Home; Rainer H Boger
Journal:  Curr Cardiol Rev       Date:  2010-05

Review 9.  Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.

Authors:  Paloma Lluch; Gloria Segarra; Pascual Medina
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

10.  Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients.

Authors:  Gaetano Iapichino; Maura Albicini; Michele Umbrello; Francesca Sacconi; Isabella Fermo; Radmila Pavlovich; Rita Paroni; Giacomo Bellani; Giovanni Mistraletti; Massimo Cugno; Antonio Pesenti; Luciano Gattinoni
Journal:  Intensive Care Med       Date:  2008-05-27       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.